Titan Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Profit before tax

24.37

31.53

28.12

28.97

38.76

Net cashflow-operating activity

20.12

21.15

21.18

21.95

17.75

Net cash used in investing activity

-9.87

-20.30

-20.73

-16.44

-4.33

Netcash used in fin. activity

-7.96

-2.87

-2.40

-4.01

-9.81

Net inc/dec in cash and equivlnt

2.29

-2.02

-1.95

1.51

3.61

Cash and equivalnt begin of year

2.84

4.86

6.81

5.31

1.70

Cash and equivalnt end of year

5.13

2.84

4.86

6.81

5.31